Methadyl Acetate: Clinical Trials

5 trials of Methadyl Acetate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 3 Phase 2, 1 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Early Phase 11Completed 1
Phase 41Completed 1

Follow Methadyl Acetate: new trials by email Literature Review of Methadyl Acetate trials Research Report on Methadyl Acetate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LAAM-HAART PET Imaging
[11c] LAAM, Ritonavir, Efavirenz - Healthy Volunteers
Early Phase 1CompletedWashington University School of Medicine102013-08-012017-12-13
Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens
Levoacetyl Methadol - Heroin Dependence, Opioid-Related Disorders
Phase 2CompletedNational Institute on Drug Abuse (NIDA)1422001-11-012017-01-12
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1
LAAM - Behavior Therapy, Cocaine
Phase 2CompletedNational Institute on Drug Abuse (NIDA)1401997-03-012017-01-12
Feasibility Study of Take-Home LAAM Medication - 3
LAAM - Opioid-Related Disorders
Phase 4CompletedUniversity of California, Los Angeles1995-03-012017-11-01
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
LAAM - Opioid-Related Disorders, Substance-Related Disorders
Phase 2CompletedNational Institute on Drug Abuse (NIDA)1991-06-012017-01-12

Conditions studied

Opioid-Related Disorders (4)  ·  Heroin Dependence (2)  ·  Substance-Related Disorders (2)

Sponsors

National Institute on Drug Abuse (NIDA) (3)  ·  University of California, Los Angeles (1)  ·  Washington University School of Medicine (1)

Countries

United States (5)

Top investigators

Alison Oliveto, Ph.D. (1)  ·  Charles O'Brien, M.D., Ph.D. (1)  ·  Evan D Kharasch, MD, PhD (1)  ·  John Grabowski, PhD (1)  ·  Walter Ling, M.D. (1)

Results publications

PMID 16002025

NIH funding

P50DA009260 (1)